联合雾化吸入治疗老年喘息型慢性支气管炎66例疗效分析  

Efficacy of 66 cases of senile chronic asthmatic bronchitis combined inhalation

作　　者：王志强 

机构地区：[1]新疆维吾尔自治区伊宁市人民医院急诊科,新疆伊宁835000

出　　处：《世界最新医学信息文摘》2013年第29期19-20,共2页World Latest Medicine Information Electronic Version

摘　　要：目的：探讨联合雾化吸入对于老年喘息型慢性支气管炎的临床疗效。方法选取于2011年4月至2013年6月入我院治疗的66例老年喘息型慢性支气管炎患者作为研究对象，按治疗时间分为对照组和观察组，每组各33例。对照组采用盐酸氨溴索氧化吸入治疗，观察组给予异丙托溴胺、硫酸特布他林和布地奈德联合雾化吸入治疗，比较两组患者的实际疗效。结果对照组的治疗总有效率为66.67%，观察组的治疗总有效率为90.91%。两组患者的治疗总有效率比较差异明显，具有统计学意义（P ＜0.05）。结论异丙托溴胺、硫酸特布他林和布地奈德联合雾化吸入治疗可有效改善老年喘息型慢性支气管炎患者的各项症状，疗效令人满意，值得临床借鉴和推广。Objective To investigate the clinical efficacy of combined nebulized for elderly chronic asthmatic bronchitis. Methods In April 2011 to June 2013 into the hospital treated 66 cases of elderly patients with chronic asthmatic bronchitis as an object of study,Divided into two groups according to duration of treatment and observation group, 33 cases in each group.The control group of ambroxol oxide inhalation treatment, observation group were given ipratropium bromide, sulfate, terbutaline and budesonide inhalation therapy, the actual effect of the two groups of patients.Results the total effective treatment in the control group was 66.67%, the treatment group observed the total effective rate 90.91%. The treatment groups were significantly different total effective rate, with statistical significance （P 〈 0.05）.Conclusion ipratropium bromide, sulfate, terbutaline and budesonide inhalation therapy can be effective in improving the symptoms in elderly patients with chronic asthmatic bronchitis,a satisfactory curative effect,is worthy of learning and promotion.

关 键 词：喘息型慢性支气管炎 异丙托溴胺 硫酸特布他林 布地奈德 

分 类 号：R562.21[医药卫生—呼吸系统]